Cargando…

Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury

BACKGROUND & AIMS: Mitochondria are the major organelles for the formation of reactive oxygen species (ROS) in the cell, and mitochondrial dysfunction has been described as a key factor in the pathogenesis of cholestatic liver disease. The methylation-controlled J-protein (MCJ) is a mitochondria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iruzubieta, Paula, Goikoetxea-Usandizaga, Naroa, Barbier-Torres, Lucía, Serrano-Maciá, Marina, Fernández-Ramos, David, Fernández-Tussy, Pablo, Gutiérrez-de-Juan, Virginia, Lachiondo-Ortega, Sofia, Simon, Jorge, Bravo, Miren, Lopitz-Otsoa, Fernando, Robles, Mercedes, Ferre-Aracil, Carlos, Varela-Rey, Marta, Elguezabal, Natalia, Calleja, José Luis, Lu, Shelly C., Milkiewicz, Malgorzata, Milkiewicz, Piotr, Anguita, Juan, Monte, María J., Marin, José J.G., López-Hoyos, Marcos, Delgado, Teresa C., Rincón, Mercedes, Crespo, Javier, Martínez-Chantar, María Luz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099785/ https://www.ncbi.nlm.nih.gov/pubmed/33997750 http://dx.doi.org/10.1016/j.jhepr.2021.100276

Ejemplares similares

The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury
por: Barbier-Torres, Lucía, et al.
Publicado: (2017)

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
por: Barbier-Torres, Lucía, et al.
Publicado: (2020)

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression
por: Juárez‐Fernández, María, et al.
Publicado: (2023)

Nutraceutical Properties of Polyphenols against Liver Diseases
por: Simón, Jorge, et al.
Publicado: (2020)

Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
por: Rodríguez-Agudo, Rubén, et al.
Publicado: (2022)

Magnesium and Liver Metabolism Through the Lifespan
por: Bravo, Miren, et al.
Publicado: (2023)

Neddylation tunes peripheral blood mononuclear cells immune response in COVID-19 patients
por: Serrano-Maciá, Marina, et al.
Publicado: (2022)

Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH
por: Simón, Jorge, et al.
Publicado: (2021)

Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis
por: Lachiondo-Ortega, Sofia, et al.
Publicado: (2019)

Ikaros mediates the DNA methylation-independent silencing of MCJ/DNAJC15 gene expression in macrophages
por: Navasa, Nicolás, et al.
Publicado: (2015)

Multi-Omics Integration Highlights the Role of Ubiquitination in CCl(4)-Induced Liver Fibrosis
por: Mercado-Gómez, Maria, et al.
Publicado: (2020)

Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
por: Fernández-Tussy, Pablo, et al.
Publicado: (2021)

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
por: Milkiewicz, Malgorzata, et al.
Publicado: (2016)

Glycolysis Induces MCJ Expression That Links T Cell Proliferation With Caspase-3 Activity and Death
por: Secinaro, Michael A., et al.
Publicado: (2019)

miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease
por: Fernández-Tussy, Pablo, et al.
Publicado: (2019)

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
por: Serrano-Maciá, Marina, et al.
Publicado: (2021)

Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma
por: Delgado, Teresa Cardoso, et al.
Publicado: (2019)

The mitochondrial negative regulator MCJ modulates the interplay between microbiota and the host during ulcerative colitis
por: Pascual-Itoiz, Miguel Angel, et al.
Publicado: (2020)

Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart
por: Hang, Tianyu, et al.
Publicado: (2023)

Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals
por: Goikoetxea‐Usandizaga, Naroa, et al.
Publicado: (2021)

A morphological method for ammonia detection in liver
por: Gutiérrez-de-Juan, Virginia, et al.
Publicado: (2017)

Conformational dynamics of the ABC transporter McjD seen by single‐molecule FRET
por: Husada, Florence, et al.
Publicado: (2018)

Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage
por: González-Recio, Irene, et al.
Publicado: (2022)

The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes
por: Mercado-Gómez, Maria, et al.
Publicado: (2022)

Structural basis for antibacterial peptide self‐immunity by the bacterial ABC transporter McjD
por: Bountra, Kiran, et al.
Publicado: (2017)

Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies
por: Milkiewicz, Malgorzata, et al.
Publicado: (2012)

Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis
por: Liebe, Roman, et al.
Publicado: (2016)

In Vivo and In Vitro Expression of iC1, a Methylation-Controlled J Protein (MCJ) in Bovine Liver, and Response to In Vitro Bovine Fatty Liver Disease Model
por: Choudhary, Shanti, et al.
Publicado: (2023)

MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
por: Fernández-Ramos, David, et al.
Publicado: (2018)

Correlation between Endosonographic and Doppler Ultrasound Features of Portal Hypertension in Patients with Cirrhosis
por: Wiechowska-Kozłowska, A., et al.
Publicado: (2012)

Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis
por: Wasik, Urszula, et al.
Publicado: (2017)

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
por: Barbier-Torres, Lucía, et al.
Publicado: (2014)

One Carbon Metabolism and S-Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes
por: Fernández-Ramos, David, et al.
Publicado: (2022)

ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2017)

The Association between SOCS1−1656G>A Polymorphism, Insulin Resistance and Obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients
por: Kempinska-Podhorodecka, Agnieszka, et al.
Publicado: (2019)

p-STAT3 is a PDC-E2 interacting partner in human cholangiocytes and hepatocytes with potential pathobiological implications
por: Kilanczyk, Ewa, et al.
Publicado: (2021)

DHEA Protects Human Cholangiocytes and Hepatocytes against Apoptosis and Oxidative Stress
por: Kilanczyk, Ewa, et al.
Publicado: (2022)

A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients
por: Kruk, Beata, et al.
Publicado: (2022)

The Role of hsa-miR-125b-5p Interaction with S1P/Ceramide Axis in the Potential Development of Inflammation-Associated Colon Cancer in Primary Sclerosing Cholangitis
por: Abramczyk, Joanna, et al.
Publicado: (2023)

SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
por: Zubiete-Franco, Imanol, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2uigha6ajm2fipcedcmdn3uu85